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Abstract 
Purpose: To investigate the anti-tumor effect of microRNA-194 (miR-194) and possible relationship with 
profilin 2. 
Methods: The expressions of miR-194 and profilin 2 were investigated via bioinformatic analysis and 
were further verified using quantitative real-time polymerase chain reaction (qRT-PCR) in both normal 
and non-small cell lung cancer (NSCLC) cells. Dual luciferase reporter assay, together with transfection, 
was applied to determine the effect of miR-194 and profilin 2 on proliferation, migration and invasion, 
and its underlying mechanisms. 
Results: Relatively low expression of miR-194 and high expression of profilin 2 in cancerous lung tissue 
were found through bioinformatic analysis and further confirmed by qRT-PCR on normal and NSCLC 
cell lines. Profilin 2 was the direct target of miR-194. Also, miR-194 overexpression inhibited the 
proliferation, migration and invasion of NSCLC cells, and this suppressive effect was partially reversed 
by transfection of pcDNA3.1-PFN2 plasmid. 
Conclusion: The results show that miR-194 plays a tumor suppressor role in NSCLC development. It 
inhibits the proliferation, migration and invasion of NSCLC cells via profilin 2 suppression. Interventions 
targeting the miR-194/profilin 2 axis may therefore serve as a clinical strategy for the prevention and 
treatment of NSCLC metastases. 
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Lung cancer is a major cause of cancer-
associated mortality worldwide. Among various 
subtypes, non-small cell lung cancer (NSCLC) is 
one of the most common which accounts for 80 
% of all diagnosed lung cancer cases [1,2]. 
Compared to small cell lung cancer (SCLC), 
patients with NSCLC are less sensitive to radio-
chemotherapy, have higher recurrence rate, and 
thus lower long-term survival rate [3]. Excessive 
proliferation and metastasis of cancer cells are 
major reasons for poor prognosis of NSCLC 
patients [4]. Therefore, identifying related genes 
and possible underlying mechanisms is of great 
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importance in improving early diagnosis of 
NSCLC and targeted therapy development. 
 
microRNA, a short non-coding RNA with length 
between 18 and 25 amino acids, is generally 
assumed to play a negative role in gene 
regulation in eukaryotic cells. Bounded to the 3’-
untranslated region (UTR), microRNA can inhibit 
target gene transcription, even leading to the 
degradation of targeted mRNA. Tumor 
development is often accompanied with 
abnormal microRNA expression and distribution. 
Thus, microRNA is not only a possible biomarker 
for early diagnosis, but also a target for future 
targeted therapy with great potential [5]. 
Relatively low expression of microRNA-194 
(miR-194) in cancers such as hepatocellular 
carcinoma, pancreatic cancer, melanoma and 
ovarian cancer have been widely reported 
previously. Abnormal miR-194 expression might 
be related to tumor progression, and thus 
suggesting poor prognosis [6,7]. Zhang et al 
reported that overexpression of miR-194 can 
inhibit migration and invasion in glioma cells [8]. 
Moreover, the proliferation of melanoma cells 
was suppressed by miR-194 overexpression [9]. 
However, the specific role of miR-194 in NSCLC 
and further underlying mechanisms have yet not 
been unveiled. 
 
Profilin, with a molecular weight between 12 and 
15 kDa, is a family of actin-binding protein 
constitutively expressed in eukaryotic cells, 
including profilin 1, 2, 3 and 4. These proteins 
are involved in cell proliferation, differentiation, 
and cell signal transduction by regulating 
polymerization and depolymerization of actin 
[10,11]. Profilin family, especially profilin 2, has 
been thoroughly studied in the field of 
tumorigenesis and development, however, with 
inconsistent results. Kim et al reported that 
profilin 2 promotes migration and invasion of 
human colorectal cancer cell line HT29 [10], 
while suppressing cell proliferation in oral 
squamous cell carcinoma [12]. Moreover, 
preliminary work shown done that profilin 2 is 
relatively overexpressed in NSCLC 95D cells and 
is possibly related to epithelial-mesenchymal 
transition (EMT) [13]. 
 
Therefore, the present study was to investigate 
the anti-tumor effect of miR-194 and possible 






The potential target gene of miR-194 was 
predicted using miRanda/mirSVR tool. In order to 
obtain the microRNA expression profile changes 
and miR-194 level changes of patients with 
NSCLC, we retrieved a high-throughput 
sequencing data from patients with lung 
squamous cell carcinoma (SCLC) in The Cancer 
Genome Atlas (TCGA) database. Selected 
dataset include 45 cases of healthy control 
tissues and 332 tumor tissues. In the Gene 
Expression Omnibus (GEO) database, we 
retrieved a microRNA microarray data about lung 
adenocarcinoma (accession ID: GSE51853) and 
different expression gene analysis was 
conducted for getting the microRNA expression 
profile. These dataset include 126 normal tissues 
and 76 tumor tissues. Moreover, for estimating 
the expression change of profilin in patients with 
NSCLC, two relevant cohort study data (Landi 





Human NSCLC cell lines (SK-MES-1, H1299, 
A549, HCC827 and H460) and human normal 
lung cell line (MRC-5) were purchased from the 
Cell Bank of the Chinese Academy of Science 
(Shanghai, China). MRC-5 and A549 cells were 
cultured in DMEM, while SK-MES-1, H1299, 
H460 and HCC827 cells were culture in RPMI-
1640 medium (with 10 % fetal bovine serum), 
supplemented with 100 U/mL penicillin and 100 
μg/mL streptomycin (all from Gibco, Carlsbad, 
CA, USA). Cells were cultured in a humidified 
environment with 5 % CO2 at 37 °C. 
 
Quantitative real-time PCR (qRT-PCR) 
 
Total RNA was extracted using TRIzol (Gibco) 
from A549 cells. miR-194 was reversed transcript 
using miScript II RT kit (Qiagen, Dusseldorf, 
Germany) and SNORD-48 was set as internal 
reference. For profilin 2 mRNA, SuperScript 
Master kit (Thermo Fisher Scientific) were used 
with GAPDH as internal reference. The fold 
change of targeted genes expressions were 




Western blot was conducted as previously 
described [14] using primary antibodies specific 
for profilin 2 and GAPDH (Sigma-Aldrich, St. 
Louis, MO, USA). Image J (US NIH, Bethesda, 
MD, USA) was used to analyze the optical 




Cell transfection was performed using 
Lipofectamine RNAiMAX kit (Thermo Fisher 
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Scientific, Waltham, MA, USA) for miR-194 
mimic and siRNA, and Lipofectamine 2000 kit 
(Thermo Fisher Scientific) for pcDNA3.1-PFN2 
plasmid, respectively. All the procedures were 
performed strictly according to the 
manufacturer’s instruction. 
 
Dual luciferase reporter assay 
 
The 3’-UTR sequence of profilin 2 mRNA 
containing wild-type or mutant miR-194 binding 
sites was synthesized and cloned into the 
PsiCHECK2 fluorescent reporter plasmid 
(Promega, Madison, WI, USA), respectively. 
Transfected cells (1×104 cells/well) were seeded 
in 96-well plates for 48 h. Relative luciferase 
activity was determined by Dual-Luciferase 
Reporter Assay System (Promega). 
 
Cell viability assay 
 
Transfected A549 cells (3 × 103 cells/well) 
seeded in 96-well plates were further cultured for 
24, 48 and 72 h, respectively. Cell viability was 
determined using CCK-8 kit (Jiancheng, Nanjing, 
China) according to the manufacturer’s 
instruction. The absorbance at 450 nm was 





A549 cells (4 × 105 cells/well) were seeded in a 
6-well plate to form a monolayer. The scratch 
assay was performed using a p200 pipet tip [15]. 
Photos were taken 72 h after the first scratch, 




A549 cells (1 × 105 cells/well) were inoculated 
into the upper chamber of Matrigel-coated 
Transwell (8 μm pore size). After 16 h incubation, 
migrated cells on were fixed with 4 % formalin, 
and further stained with Giemsa and counted 




All data are presented as mean ± SD (n = 3). 
Statistical analysis using Student’s t test, Mann-
Whitney U test or one-way ANOVA followed by 
Dunnett’s test was performed. P-value was 
calculated using Prism software (GraphPad, La 
Jolla, CA, USA), and values < 0.05 were 







Bioinformatic data on miR-194 and profilin 
expressions in patients with NSCLC 
 
According to the dataset retrieved from TCGA, 
the median level of miR-194 was lower in SCLC 
tissues compared with matched normal tissues 
(Figure 1, fold change=0.8, p < 0.05). The 
microarray data from GEO also showed that 
miR-194 level decreased in lung 
adenocarcinoma tissues compared with normal 
tissue (Figure 1, p < 0.05). The data from 
Oncomine database demonstrated higher profilin 
2 level both in SCLC tissues and lung 
adenocarcinoma tissues (Figure 2). These 
results indicated that miR-194 and profilin may 




Figure 1: MiR-194 expression in normal and cancerous lung tissue. Datasets were retrieved from TCGA and 
GEO; *: p < 0.05 vs normal tissue 
Zhang et al 










Figure 3: Relative expression level of miR-194 and profilin 2 in normal (MRC-5) and cancerous (SK-MES-1, 
A549, H1299, H460 and HCC827) lung cell lines; *p < 0.05 vs MRC-5 
 
MiR-194 and profilin 2 expression in different 
cell lines 
 
As shown in Figure 3, the relative level of miR-
194 in NSCLC cell lines was lower than that in 
normal human lung cell line MRC-5 cells (p < 
0.05), while the level of profilin 2 mRNA was 
higher than that in MRC-5 cells (p < 0.05). Those 
cell lines with lower miR-194 levels had higher 
profilin 2 mRNA levels. 
 
 
Profilin 2, a downstream target of miR-194 
 
Results predicted by TargetScan and 
miRanda/mirSVR software suggested that profilin 
2 is a potential target of miR-194. Dual luciferase 
reporter assay revealed that the fluorescence 
intensity of cells transfected with PsiCHECK2-
PFN2-WT+miR-194 mimic was significantly 
reduced compared to cells transfected with 
PsiCHECK2-PFN2-WT+mimic negative control 
(Figure 4, p < 0.05). However, the fluorescence 
intensity of cells transfected with PsiCHECK2-
PFN2-MUT+miR-194 mimic was comparable to 
those transfected with PsiCHECK2-PFN2-
MUT+mimic negative control (p > 0.05), 
suggesting that the 3’-UTR region of profilin 2 
mRNA can be the direct binding site of miR-194. 
Results from qRT-PCR (Figure 5) and Western 
blot (Figure 6) showed that both profilin 2 mRNA 
and protein levels were decreased in miR-194 
mimic transfected cells (p < 0.05). 
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Figure 4: Dual luciferase reporter assay. A549 cells 
were transfected as indicated. WT: wild-type; MUT: 




Figure 5: Profilin 2 mRNA level determined by qRT-
PCR. A549 cells were transfected as indicated. NG: 
negative; *p < 0.05 vs control; #p < 0.05 vs miR-194 
mimic; △p < 0.05 vs PFN2-siRNA 
 
Effect of miR-194/profilin 2 axis on A549 cell 
proliferation, migration and invasion 
 
The CCK-8 cell viability assay showed that the 
relative proliferation rate of A549 cells 
overexpressed with miR-194 was lower than that 
of negative control (Figure 7, p < 0.05). The in 
vitro scratch assay revealed that, the migration of 
cells was slower after miR-194 overexpression, 
and the gap length at 72 h was larger than that of 
the negative control group (Figure 8, p < 0.05). 
Transwell assay showed that the number of 
migrated cells was decreased after miR-194 
overexpression, compared with the negative 
control group (Figure 9, p < 0.05). Similar to the 
effect of miR-194 overexpression, cell 
proliferation was inhibited and the migration and 
invasion abilities also decreased after silencing 
profilin 2 using siRNA. However, the transfection 
of miR-194 mimic into pcDNA3.1-PFN2-
transfected A549 cells partially restored the 
proliferation, migration and invasion ability, 
compared with the cells overexpressing miR-194 
only, which indicated that the recovery of profilin 
2 levels partially abolished the tumor suppressor 
effect of miR-194. The above results suggest that 
miR-194 may play a suppressor effect on 





Figure 6: Profilin 2 protein level determined by 
Western blot. A549 cells were transfected as 
indicated. NG: negative; *p < 0.05 vs control; #p < 0.05 
vs miR-194 mimic; △p < 0.05 vs PFN2-siRNA 
 
 
Figure 7: Relative proliferation rate determined by 
CCK-8 assay. A549 cells were transfected as 
indicated. NG: negative; *p < 0.05 vs control; #p < 0.05 
vs miR-194 mimic; △p < 0.05 vs PFN2-siRNA 
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Figure 8: Cell migration ability determined by in vitro 
scratch assay. A549 cells were transfected as 
indicated. NG: negative; *p < 0.05 vs control; #p < 0.05 
vs miR-194 mimic; △p < 0.05 vs PFN2-siRNA 
 
 
Figure 9: Cell invasion ability determined by Transwell 
assay. A549 cells were transfected as indicated. NG: 
negative; *p < 0.05 vs control; #p < 0.05 vs miR-194 




In our present study, results from bioinformatic 
analysis showed that there were abnormal 
expressions of miR-194 and profilin 2 in normal 
and cancerous lung tissues, with relatively low 
miR-194 expression and high profilin 2 
expression in NSCLC patients. The results were 
further confirmed by in vitro PCR assay using 
different NSCLC cell lines, compared to normal 
human lung cells, which suggest possible 
relationship between these two molecules. 
Further dual luciferase reporter assay showed 
that profilin 2 is the direct target of miR-194 in 
A549 cells. Overexpression of miR-194 could 
suppress profilin 2 expression both at mRNA and 
protein level, and further inhibit proliferation, 
migration and invasion of A549 cells. Similar 
results were found in profilin 2-knockdown A549 
cells using siRNA interference. Of note, the 
suppressive effect was partially reversed by 
overexpression of profilin 2.  
 
Previous studies related to miR-194 mainly 
focused on its suppressive effect on cell 
migration and invasion via EMT-related genes 
and signaling pathways. Meng et al reported that 
miR-194 is relatively lowly expressed in 
mesenchymal-like hepatic epithelial cell [7]. 
Overexpression of miR-194 can down-regulated 
mesenchymal cell marker expression, indicating 
the EMT process was inhibited. The metastasis 
of liver cancer cells was also suppressed in an 
animal model [7]. Similar expression pattern of 
miR-194 was also found in gastric cancer cells. 
miR-194 transfection could reverse the EMT 
progression, and thus inhibit migration and 
invasion of gastric cancer cell [16]. BMI-1, an 
important EMT inducer, is also a potential target 
of miR-194 in endometrial cancer cells [17]. 
Moreover, Kong et al reported that miR-194 
could inhibit NudC nuclear distribution protein 
(hNUDC) expression, and thus suppresses 
migration and invasion of both PC-3 and DU-145 
human prostate cancer cell lines [18]. Besides, 
miR-194 also exerted its anti-proliferative effect 
on osteosarcoma cells via CDH2 and IGF1R 
[19]. Furthermore, miR-194 exhibited pro-
apoptotic effect on melanoma cells by 
modulating PI3K/AKT/FoxO3a and p53/p21 
signaling pathway [9]. 
 
Currently, there are few studies on the role and 
underlying mechanism of miR-194 in NSCLC. 
Zhou et al found that there is relatively low 
expression of miR-194 in NSCLC patients [20]. 
After the restoration of miR-194 level in vitro, the 
proliferation of tumor cells was inhibited, 
suggesting that the anti-tumor effect of miR-194 
may be through the inhibition of its target gene 
hNUDC [20]. However, due to small sample size, 
multiple downstream targets and complex 
regulation network of microRNAs, more studies 
were warranted to validate the possible target 
genes of miR-194 and reveal its role in the 
development of NSCLC. 
 
In the present study, by using bioinformatic 
analysis, we analyzed large data from TCGA 
database. The results suggest that there is low 
expression of miR-194 in NSCLC patients, which 
is consistent with the previous results. Moreover, 
the bioinformatics results were confirmed by in 
vitro assays. After transfection with the miR-194 
mimic sequence, we found that the proliferation, 
migration and invasion of A549 cells were 
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inhibited, suggesting the tumor suppressor 
function of miR-194 in NSCLC.  
 
In order to further reveal the mechanism of action 
of miR-194, we analyzed the potential target 
gene profilin 2 in NSCLC. Bioinformatic analysis 
of two related cohort findings found that patients 
with NSCLC had high expression of profilin 2. In 
vitro analysis of NSCLC cell lines revealed that 
not only the profilin 2 level in the NSCLC cell 
lines was higher than in the normal lung cancer 
cell line, but the profilin 2 in the NSCLC cell line 
with lower miR-194 was rather higher. Further 
dual luciferase reporter assays, qRT-PCR and 
Western blot assays also validated profilin 2 as 
the possible target of miR-194.  
 
At present, there are only few studies on the 
specific role of profilin 2 in NSCLC, while 
research have found that profilin 2 can promote 
cell migration and invasion in other types of 
cancer. Kim et al. found that reducing the 
expression of profilin 2 in colorectal cancer stem 
cells HT29 can not only inhibit the EMT process, 
but also inhibit cell migration and invasion [10]. 
Cui et al found that profilin 2 levels correlate with 
the clinicopathological features of esophageal 
cancer, with a poorer prognosis for patients with 
higher profilin 2 levels [21].  
 
Downregulation of profilin 2 in vitro can inhibit 
esophageal cancer cell proliferation, migration 
and invasion, accompanied by changes in EMT 
markers, with significant decrease of 
mesenchymal markers [21]. These biological 
effects of profilin 2 may be achieved through the 
regulation of some signaling pathways, such as 
PI3K/AKT and TGF-β/Smad [22]. This present 
study found that cell proliferation, migration and 
invasion of A549 were inhibited after the 
silencing of profilin 2. Overexpression of profilin 2 
can eliminate the tumor suppressor effect of miR-
194 overexpression, manifested as promoted cell 
proliferation, migration and invasion. 
Furthermore, the investigation of the effect of 
miR-194/profilin 2 axis on EMT of NSCLC cells is 




The findings of this study suggest that 
dysregulated miR-194/profilin 2 axis is involved 
in the development of NSCLC. MiR-194 plays a 
tumor suppressor role in NSCLC development. It 
inhibits the proliferation, migration and invasion 
of NSCLC cells by targeting profilin 2. 
Interventions targeting the miR-194/profilin 2 axis 
may therefore serve as a clinical strategy for the 
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